Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1037605

registered interest
date	08/01/2019
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Post-18 Education and Funding Review
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government when their review of post-18 education and funding will be published.
tabling member printed	Lord Goodlad
uin	HL12661
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>The Review of Post-18 Education and Funding is being informed by independent advice from an expert panel, chaired by Philip Augar.</p><p> </p><p>The panel have undertaken an extensive programme of stakeholder engagement and evidence gathering. They will report in 2019 before government concludes the overall review.</p><p>The government will want to move swiftly to improve the post-18 system once the review has concluded. Implementation timetables will depend on the review’s findings and recommendations and the legislative and operational requirements.</p><p> </p> answering member printed Viscount Younger of Leckie question first answered 18/01/2019 11:25:54 answering member 4169 label Biography information for Viscount Younger of Leckie
tabling member	670 label Biography information for Lord Goodlad

1039040

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bedrocan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times (a) he, (b) Ministers in his Department and (c) officials in his Department have met with Bedrocan.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207194
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Departmental officials have communicated with a range of manufacturers and importers regarding the establishment of supplies of cannabis-based products for medicinal use in the United Kingdom.</p><p> </p><p>Whilst the Secretary of State for Health and Social Care has not met with Bedrocan, Tilray, GW Pharmaceuticals or Aphria, the former Parliamentary Under Secretary of State (Lord O’Shaughnessy) did meet with GW Pharmaceuticals once.</p><p> </p><p>Since January 2018, officials from the Department have met with Bedrocan once, Tilray three times and GW Pharmaceuticals seven times (including a meeting which involved the Department’s Chief Scientific Advisor). No meetings have taken place between Departmental officials and Aphria.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 207195 207196 207197 question first answered 18/01/2019 12:01:09 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning

1039041

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tilray
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times (a) he, (b) Ministers in his Department and (c) officials in his Department have met with Tilray.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207195
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Departmental officials have communicated with a range of manufacturers and importers regarding the establishment of supplies of cannabis-based products for medicinal use in the United Kingdom.</p><p> </p><p>Whilst the Secretary of State for Health and Social Care has not met with Bedrocan, Tilray, GW Pharmaceuticals or Aphria, the former Parliamentary Under Secretary of State (Lord O’Shaughnessy) did meet with GW Pharmaceuticals once.</p><p> </p><p>Since January 2018, officials from the Department have met with Bedrocan once, Tilray three times and GW Pharmaceuticals seven times (including a meeting which involved the Department’s Chief Scientific Advisor). No meetings have taken place between Departmental officials and Aphria.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 207194 207196 207197 question first answered 18/01/2019 12:01:09 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning

1039042

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	GW Pharmaceuticals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times (a) he, (b) Ministers in his Department and (c) officials in his Department have met with GW Pharmaceuticals.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207196
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Departmental officials have communicated with a range of manufacturers and importers regarding the establishment of supplies of cannabis-based products for medicinal use in the United Kingdom.</p><p> </p><p>Whilst the Secretary of State for Health and Social Care has not met with Bedrocan, Tilray, GW Pharmaceuticals or Aphria, the former Parliamentary Under Secretary of State (Lord O’Shaughnessy) did meet with GW Pharmaceuticals once.</p><p> </p><p>Since January 2018, officials from the Department have met with Bedrocan once, Tilray three times and GW Pharmaceuticals seven times (including a meeting which involved the Department’s Chief Scientific Advisor). No meetings have taken place between Departmental officials and Aphria.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 207194 207195 207197 question first answered 18/01/2019 12:01:09 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning

1039043

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Aphria
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times (a) he, (b) Ministers in his Department and (c) officials in his Department have met with Aphria.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207197
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Departmental officials have communicated with a range of manufacturers and importers regarding the establishment of supplies of cannabis-based products for medicinal use in the United Kingdom.</p><p> </p><p>Whilst the Secretary of State for Health and Social Care has not met with Bedrocan, Tilray, GW Pharmaceuticals or Aphria, the former Parliamentary Under Secretary of State (Lord O’Shaughnessy) did meet with GW Pharmaceuticals once.</p><p> </p><p>Since January 2018, officials from the Department have met with Bedrocan once, Tilray three times and GW Pharmaceuticals seven times (including a meeting which involved the Department’s Chief Scientific Advisor). No meetings have taken place between Departmental officials and Aphria.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 207194 207195 207196 question first answered 18/01/2019 12:01:09 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning

1041401

registered interest
date	14/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Health: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of children aged five had at least one missing, decayed or filled tooth in each of the last eight years .
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	208231
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Data on five year old dental health is not collected annually. Data on the proportion of five year olds with at least one missing, decayed or filled tooth because of decay available for the last eight years is in the following table. These data are not comparable due to changes in methodology between the surveys.</p><p> </p><p>Data collection for the 2018/19 survey is currently underway and results will be published in spring 2020.</p><p> </p><p>Data from the surveys of five year old children can be viewed at the following link:</p><p> </p><p><a href="http://www.nwph.net/dentalhealth/5year%20docs.aspx" target="_blank">http://www.nwph.net/dentalhealth/5year%20docs.aspx</a></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Proportion of five year old children with one or more teeth affected by decay</p></td></tr><tr><td><p>2012<sup>1</sup></p></td><td><p>28%</p></td></tr><tr><td><p>2013<sup>2</sup></p></td><td><p>25%</p></td></tr><tr><td><p>2015<sup>3</sup></p></td><td><p>24.7%</p></td></tr><tr><td><p>2017<sup>3</sup></p></td><td><p>23.3%</p></td></tr></tbody></table><p> </p><p>Notes:</p><p>- Caution is advised when making comparisons of these data as they come from different data sets</p><p>- <sup>1</sup> Source: former NHS Dental Epidemiology Programme</p><p>- <sup>2 </sup>Source: Child Dental Health Survey, 2013</p><p>- <sup>3 </sup>Source: Public Health England Dental Public Health Intelligence Programme</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2019 12:06:05 answering member 4067 label Biography information for Steve Brine previous answer version 96129 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

1041305

registered interest
date	14/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of Prescription Ordering Direct services' ability to deny or delay repeat prescription requests from patients with lifelong or long-term illnesses or diseases for whom their GP has always previously and continues to prescribe such medication on the health of such patients.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	208241
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>The Department has no such plans to make an assessment. It is important that patients can access their prescribed medicines in a timely and convenient manner, and any service introduced should not hinder general practitioner’s ability to provide this.</p><p> </p><p>The General Medical Council’s Prescribing Guidance has specific recommendations on this topic, and explains that prescribers “must make sure that any repeat prescription they sign is safe and appropriate” and “repeat prescriptions received earlier or later than expected may indicate poor adherence, leading to inadequate therapy or adverse effects”.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2019 12:07:52 answering member 4067 label Biography information for Steve Brine previous answer version 96130 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

1041259

registered interest
date	14/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gambling: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding from the £20.5 billion of investment announced in the NHS Long Term Plan will be allocated to clinics dedicated to the treatment of problem gambling.
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	208214
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>The allocation of funding to the expansion of specialist treatment for gambling related harm announced in the NHS Long Term Plan has yet to be determined by NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2019 12:08:57 answering member 4067 label Biography information for Steve Brine previous answer version 96128 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

1039039

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of hospital trusts in implementing the law change of 1 November 2018 to ensure patients that might benefit from medical cannabis are able to.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207193
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>The Government has not made an assessment of the effectiveness of National Health Service trusts in implementing the change of law.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2019 12:10:50 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning

1039035

registered interest
date	10/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions (a) he, (b) Ministers in his Department and (c) officials in his Department with NHS Trusts on implementing adequate measures to ensure access to medical cannabis for patients.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	207190
answer	answer is ministerial correction date of answer 18/01/2019 answer text <p>Officials in the Department have worked with colleagues in NHS England, the Medicines and Healthcare products Regulatory Agency, the Home Office and individual National Health Service trusts, as necessary, to ensure that individual patients can access cannabis-based medicinal products where specialist doctors have decided this would be clinically beneficial.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2019 12:12:16 answering member 4067 label Biography information for Steve Brine
tabling member	1528 label Biography information for Sir Mike Penning